Shuang Liang, Danyang Liu, Zhengwu Xiao, Jonathan Greenbaum, Hui Shen, Hongmei Xiao, & Hongwen Deng. (2023). Repurposing Approved Drugs for Sarcopenia Based on Transcriptomics Data in Humans. MDPI AG.
Chicago Style (17th ed.) CitationShuang Liang, Danyang Liu, Zhengwu Xiao, Jonathan Greenbaum, Hui Shen, Hongmei Xiao, and Hongwen Deng. Repurposing Approved Drugs for Sarcopenia Based on Transcriptomics Data in Humans. MDPI AG, 2023.
MLA (9th ed.) CitationShuang Liang, et al. Repurposing Approved Drugs for Sarcopenia Based on Transcriptomics Data in Humans. MDPI AG, 2023.
Warning: These citations may not always be 100% accurate.